|
GB1045031A
(en)
|
1963-04-30 |
1966-10-05 |
Iwao Kawakami |
Dentifrice
|
|
US3574859A
(en)
|
1968-07-05 |
1971-04-13 |
Carl M Kosti |
Process for the treatment of hypertrophied gums
|
|
US3822349A
(en)
|
1969-06-02 |
1974-07-02 |
C Kosti |
Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
|
|
CA950833A
(en)
|
1971-02-02 |
1974-07-09 |
Carl M. Kosti |
Composition for the treatment of hypertrophied oral tissue
|
|
GB1338169A
(en)
|
1971-03-09 |
1973-11-21 |
Smith Kline French Lab |
Ureas thioureas and guanidines
|
|
US3832460A
(en)
|
1971-03-19 |
1974-08-27 |
C Kosti |
Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
|
|
US3839522A
(en)
|
1971-08-02 |
1974-10-01 |
Batley Janss Enterprises |
Process for the manufacture of dog bedding
|
|
CH630808A5
(en)
|
1976-05-08 |
1982-07-15 |
Uscio Heinz D |
Process for aromatising pharmaceutical preparations for veterinary medicine
|
|
GB1565966A
(en)
|
1976-08-04 |
1980-04-23 |
Allen & Hanburys Ltd |
Aminoalkyl furan derivatives
|
|
ES8101067A1
(es)
|
1978-08-25 |
1980-12-01 |
Thomae Gmbh Dr K |
Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
|
|
DE2841668A1
(de)
|
1978-09-25 |
1980-04-10 |
Bayer Ag |
Medikiertes tierfutter auf basis lebermehl
|
|
US4256743A
(en)
|
1979-02-22 |
1981-03-17 |
President And Fellows Of Harvard College |
Inhibition of bone resorption with H1 -blocking antihistamines
|
|
JPS6056143B2
(ja)
|
1979-08-02 |
1985-12-09 |
山之内製薬株式会社 |
アミジン誘導体ならびにその製造法
|
|
US4293557A
(en)
|
1979-07-03 |
1981-10-06 |
Teikoku Hormone Mfg. Co., Ltd. |
Antiulcer phenoxypropylamine derivatives
|
|
US4375547A
(en)
|
1980-10-02 |
1983-03-01 |
Eli Lilly And Company |
N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
|
|
IT1209431B
(it)
|
1980-11-28 |
1989-07-16 |
Angeli Inst Spa |
Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.
|
|
DE3124090A1
(de)
|
1981-06-19 |
1983-01-05 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale dipyridamolformen
|
|
US4704284A
(en)
|
1982-08-12 |
1987-11-03 |
Pfizer Inc. |
Long-acting matrix tablet formulations
|
|
DE3237575A1
(de)
|
1982-10-09 |
1984-04-12 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue orale mopidamolformen
|
|
GB8313217D0
(en)
|
1983-05-13 |
1983-06-22 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
|
JPS59222406A
(ja)
|
1983-06-01 |
1984-12-14 |
Teijin Ltd |
歯周疾患治療用製剤及びその製造法
|
|
US4732915A
(en)
|
1983-11-02 |
1988-03-22 |
Alza Corporation |
Process for increasing solubility of drug
|
|
DE3346123A1
(de)
|
1983-12-21 |
1985-06-27 |
Janssen Pharmaceutica, N.V., Beerse |
Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
|
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
|
US6407079B1
(en)
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
DE3677316D1
(de)
|
1985-10-17 |
1991-03-07 |
Smith Kline French Lab |
4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate.
|
|
IE63321B1
(en)
|
1986-02-03 |
1995-04-05 |
Elan Corp Plc |
Drug delivery system
|
|
JPS62223112A
(ja)
|
1986-03-25 |
1987-10-01 |
Rooto Seiyaku Kk |
歯周病治療剤
|
|
JPH0759496B2
(ja)
|
1986-03-25 |
1995-06-28 |
ロ−ト製薬株式会社 |
歯周病治療剤
|
|
IT1204901B
(it)
|
1986-06-25 |
1989-03-10 |
Iscofar Sas |
Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria
|
|
US4868182A
(en)
|
1986-11-05 |
1989-09-19 |
Merrell Dow Pharmaceuticals Inc. |
Enhancement of prazosin
|
|
ZA878182B
(en)
|
1986-11-05 |
1988-05-02 |
Merrell Dow Pharmaceuticals Inc. |
Enhancement of prazosin
|
|
NL193682C
(nl)
|
1987-05-14 |
2000-07-04 |
Glaxo Group Ltd |
Beklede cefuroximaxetilsamenstelling.
|
|
DE3728244A1
(de)
|
1987-08-25 |
1989-03-09 |
Thomae Gmbh Dr K |
Neue (-)-benzimidazole, deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
EP0306846A3
(de)
|
1987-09-11 |
1990-05-02 |
Dr. Karl Thomae GmbH |
Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
|
|
SE8704436D0
(sv)
|
1987-11-13 |
1987-11-13 |
Pm Konsult Handelsbolag |
Anvendning av antisekretoriska substanser for nya indikationer
|
|
US4851226A
(en)
|
1987-11-16 |
1989-07-25 |
Mcneil Consumer Products Company |
Chewable medicament tablet containing means for taste masking
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
DE3804490A1
(de)
|
1988-02-12 |
1989-08-24 |
Heumann Pharma Gmbh & Co |
Substituierte 6-phenyldihydro-3(2h)-pyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE3805635A1
(de)
|
1988-02-24 |
1989-09-07 |
Thomae Gmbh Dr K |
Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
|
|
IE62095B1
(en)
|
1988-03-29 |
1994-12-14 |
Univ Florida |
Pharmaceutical formulations for parenteral use
|
|
EP0335545B2
(en)
|
1988-03-29 |
1998-09-23 |
University Of Florida |
Pharmaceutical formulations for parenteral use
|
|
EP0349657A1
(en)
|
1988-06-06 |
1990-01-10 |
Carl Richard Thornfeldt |
Manufacture of a medicament for the treatment of teething and colic
|
|
GB8824458D0
(en)
|
1988-10-19 |
1988-11-23 |
Orion Yhtymae Oy |
Substituted pyridazinones
|
|
GB8903130D0
(en)
|
1989-02-11 |
1989-03-30 |
Orion Yhtymae Oy |
Substituted pyridazinones
|
|
DE4001622A1
(de)
|
1990-01-20 |
1991-07-25 |
Thomae Gmbh Dr K |
Orale arzneimittelformen von pimobendan
|
|
US5364646A
(en)
|
1990-01-10 |
1994-11-15 |
Dr. Karl Thomae Gmbh |
Oral pharmaceutical forms of pimobendan
|
|
DE4001623A1
(de)
|
1990-01-20 |
1991-07-25 |
Thomae Gmbh Dr K |
Verwendung von benzimidazolen zur herstellung eines zur behandlung von akuten und chronischen obstruktiven atemwegserkrankungen geeigneten arzneimittels
|
|
US5188836A
(en)
|
1990-07-27 |
1993-02-23 |
Warner-Lambert Company |
Sustained release formulations
|
|
JPH0489428A
(ja)
|
1990-07-30 |
1992-03-23 |
Kao Corp |
多形核白血球活性化剤
|
|
GB2251615B
(en)
|
1991-01-03 |
1995-02-08 |
Orion Yhtymae Oy |
(-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
|
|
JPH0570612A
(ja)
|
1991-09-12 |
1993-03-23 |
Toyobo Co Ltd |
二軸配向ポリエステルフイルム
|
|
US5571533A
(en)
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
|
PT760648E
(pt)
|
1994-05-20 |
2002-04-29 |
Janssen Pharmaceutica Nv |
Tabletes de flubendazole de mastigacao para animais domesticos
|
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
JPH11228302A
(ja)
|
1998-02-18 |
1999-08-24 |
Taisho Technos Co Ltd |
抗菌防黴組成物
|
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
WO2000012137A1
(en)
|
1998-09-02 |
2000-03-09 |
Allergan Sales, Inc. |
Preserved cyclodextrin-containing compositions
|
|
DE69823240T2
(de)
|
1998-10-23 |
2005-04-28 |
Toray Industries, Inc. |
Immunmodulierende arzneimittelzusammenstellung
|
|
JP2002544220A
(ja)
|
1999-05-17 |
2002-12-24 |
デー．ベー．エフ． |
植物物質を含有する顆粒及びその製造方法
|
|
FR2793688B1
(fr)
|
1999-05-21 |
2003-06-13 |
Ethypharm Lab Prod Ethiques |
Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
|
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
GB2356346A
(en)
|
1999-11-19 |
2001-05-23 |
Mars Uk Ltd |
Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
|
|
CN1416341B
(zh)
|
2000-02-04 |
2010-05-05 |
武田药品工业株式会社 |
稳定的乳液组合物
|
|
PT1260215E
(pt)
|
2000-03-01 |
2009-09-03 |
Eisai R&D Man Co Ltd |
Comprimido de desintegração rápida que contém poli(álcool vinílico)
|
|
EP1311292A2
(en)
|
2000-06-21 |
2003-05-21 |
Bristol-Myers Squibb Pharma Company |
Vitronectin receptor antagonist pharmaceuticals
|
|
ES2292598T3
(es)
|
2000-06-27 |
2008-03-16 |
Vectura Limited |
Metodo para producir particulas para usar en una composicion farmaceutica.
|
|
US6620439B1
(en)
|
2000-10-03 |
2003-09-16 |
Atul M. Mehta |
Chrono delivery formulations and method of use thereof
|
|
UA80393C2
(uk)
|
2000-12-07 |
2007-09-25 |
Алтана Фарма Аг |
Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
|
|
AU2001225816B2
(en)
|
2000-12-18 |
2005-10-13 |
Novartis Ag |
Therapeutic combination of amlodipine and benazepril
|
|
EP1247456A3
(en)
|
2001-02-28 |
2003-12-10 |
Pfizer Products Inc. |
Palatable pharmaceutical compositions for companion animals
|
|
EP1363898A4
(en)
|
2001-03-02 |
2004-12-08 |
Bristol Myers Squibb Co |
COMPOUNDS SUITABLE AS MODULATORS OF MELANOCORTIN RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
|
DE60237696D1
(de)
|
2001-08-01 |
2010-10-28 |
Univ Utah |
Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
|
|
US6669955B2
(en)
|
2001-08-28 |
2003-12-30 |
Longwood Pharmaceutical Research, Inc. |
Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
|
|
EP1478404A1
(en)
|
2002-02-22 |
2004-11-24 |
Pharmacia Corporation |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
|
US20030190343A1
(en)
|
2002-03-05 |
2003-10-09 |
Pfizer Inc. |
Palatable pharmaceutical compositions for companion animals
|
|
DE10209982A1
(de)
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma |
Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
|
|
CO5400144A1
(es)
|
2002-03-11 |
2004-05-31 |
Novartis Ag |
Compuestos organicos
|
|
TW200306799A
(en)
|
2002-05-17 |
2003-12-01 |
Novartis Ag |
Combination of organic compounds
|
|
MXPA04010951A
(es)
|
2002-05-23 |
2005-06-08 |
Pfizer |
Nueva combinacion.
|
|
SI21223A
(sl)
|
2002-06-19 |
2003-12-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
|
|
DE10228049A1
(de)
|
2002-06-24 |
2004-01-15 |
Merck Patent Gmbh |
Flüssige Zubereitung enthaltend Oligopeptide
|
|
US20040037869A1
(en)
|
2002-08-16 |
2004-02-26 |
Douglas Cleverly |
Non-animal product containing veterinary formulations
|
|
EP1554267A1
(en)
|
2002-10-07 |
2005-07-20 |
Artesian Therapeutics, Inc. |
Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
|
|
CA2506741A1
(en)
|
2002-11-27 |
2004-06-17 |
Artesian Therapeutics, Inc. |
Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure
|
|
JP2006513238A
(ja)
|
2002-12-19 |
2006-04-20 |
ファルマシア・コーポレーション |
吸湿性薬物を含む非‐吸湿性製剤
|
|
AU2003300297A1
(en)
|
2002-12-23 |
2004-07-22 |
Artesian Therapeutics, Inc. |
CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST Beta-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
|
|
US20050085446A1
(en)
|
2003-04-14 |
2005-04-21 |
Babu M.K. M. |
Fluoroquinolone formulations and methods of making and using the same
|
|
WO2005035505A2
(en)
|
2003-09-30 |
2005-04-21 |
Artesian Therapeutics, Inc. |
Compounds with phosphodiesterase inhibiting and calcium channel blocking activities
|
|
DE102004011512B4
(de)
|
2004-03-08 |
2022-01-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmazeutische Zubereitung enthaltend Pimobendan
|
|
US8980894B2
(en)
*
|
2004-03-25 |
2015-03-17 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
|
|
EP1579862A1
(en)
*
|
2004-03-25 |
2005-09-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
|
|
JP2005281283A
(ja)
|
2004-03-31 |
2005-10-13 |
Akira Matsumori |
ベンズイミダゾール系薬剤の併用医薬
|
|
BRPI0509592A
(pt)
|
2004-05-06 |
2007-09-25 |
Cydex Inc |
formulações de sabor mascarado, contendo sertralina e ciclodextrina de éter de sulfoalquila
|
|
FI20040675A0
(fi)
|
2004-05-12 |
2004-05-12 |
Orion Corp |
Menetelmä sydämen hypertrofian hoitoon ja estoon
|
|
US20090181083A1
(en)
|
2004-06-28 |
2009-07-16 |
Lifebycle Pharmas A/S |
Porous tablets as carriers for liquid formulations
|
|
NZ534939A
(en)
|
2004-08-26 |
2007-04-27 |
Bomac Research Ltd |
Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
|
|
JP2008521805A
(ja)
|
2004-11-30 |
2008-06-26 |
アーテシアン セラピューティクス， インコーポレイテッド |
β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
|
|
US20080090827A1
(en)
|
2004-11-30 |
2008-04-17 |
Artesian Therapeutics, Inc. |
Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
|
|
CN1702243A
(zh)
|
2005-05-31 |
2005-11-30 |
刘坚雄 |
无壁板框架结构装配组合式房屋建筑及其建造方法
|
|
JPWO2006134877A1
(ja)
|
2005-06-13 |
2009-01-08 |
武田薬品工業株式会社 |
注射剤
|
|
US20090149434A1
(en)
|
2005-09-29 |
2009-06-11 |
Joseph Podolski |
Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
DK1951227T3
(en)
|
2005-11-14 |
2017-07-10 |
Boehringer Ingelheim Vetmedica Gmbh |
APPLICATION OF PIMOBENDAN TO TREAT ASYMPTOMATIC (OCCULT) HEART FAILURE
|
|
JP4572300B2
(ja)
|
2006-01-19 |
2010-11-04 |
トーアエイヨー株式会社 |
ピモベンダン経口投与製剤
|
|
MX2008012496A
(es)
|
2006-03-28 |
2009-01-07 |
Javelin Pharmaceuticals Inc |
Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina.
|
|
PE20080697A1
(es)
|
2006-05-03 |
2008-08-05 |
Boehringer Ingelheim Int |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
EP1920785A1
(en)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Liquid preparation comprising a complex of pimobendan and cyclodextrin
|
|
FR2917975B1
(fr)
|
2007-06-26 |
2009-10-16 |
Ceva Sante Animale Sa |
Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
|
|
EP2057982A1
(en)
|
2007-11-09 |
2009-05-13 |
Archimedes Development Limited |
Intranasal compositions
|
|
EP2106786A1
(de)
|
2008-04-04 |
2009-10-07 |
Roewer, Norbert, Univ.-Prof. Dr. med. |
Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
|
|
FR2934156B1
(fr)
|
2008-07-23 |
2010-09-24 |
Virbac |
Medicament appetissant a administration orale sous forme solide
|
|
WO2010055119A2
(en)
|
2008-11-17 |
2010-05-20 |
Novartis Ag |
Pharmaceutical composition comprising pimobendan
|
|
WO2010060874A1
(en)
|
2008-11-25 |
2010-06-03 |
Boehringer Ingelheim Vetmedica Gmbh |
Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
|
|
US20100166857A1
(en)
|
2008-12-30 |
2010-07-01 |
Dong Yan |
Pharmaceutical dosage forms and methods of manufacturing same
|
|
GB0912646D0
(en)
|
2009-07-21 |
2009-08-26 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
CN102264372B
(zh)
|
2009-08-31 |
2012-07-11 |
西安力邦医药科技有限责任公司 |
氟维司群纳米球/微球及其制备方法和用途
|
|
EP2485716A2
(en)
|
2009-10-07 |
2012-08-15 |
LEK Pharmaceuticals d.d. |
Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
|
|
NL1037569C2
(en)
|
2009-12-18 |
2011-06-21 |
Eurovet Animal Health B V |
Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
|
|
EP2338480A1
(en)
|
2009-12-22 |
2011-06-29 |
LEK Pharmaceuticals d.d. |
Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
|
|
JP5813391B2
(ja)
|
2011-06-24 |
2015-11-17 |
日東電工株式会社 |
粒子製剤の製造方法
|
|
CN102805733B
(zh)
|
2011-06-01 |
2016-03-09 |
日东电工株式会社 |
颗粒制剂及其制造方法
|
|
KR20140057604A
(ko)
|
2011-08-12 |
2014-05-13 |
베링거잉겔하임베트메디카게엠베하 |
고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
|
|
AU2012101682B4
(en)
|
2011-11-20 |
2013-10-24 |
Betrola Investments Pty Limited |
Formulation
|
|
RU2014129508A
(ru)
|
2011-12-21 |
2016-02-10 |
Новартис Тиргезундхайт АГ |
Новая комбинация
|
|
US10398705B2
(en)
|
2012-03-15 |
2019-09-03 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
|
|
GB201207886D0
(en)
|
2012-05-04 |
2012-06-20 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
CN104619345A
(zh)
|
2012-05-18 |
2015-05-13 |
罗达制药有限公司 |
液体制剂
|
|
FR3002736B1
(fr)
|
2013-03-04 |
2015-06-26 |
Virbac |
Composition orale nutritionnelle et medicamenteuse a usage veterinaire
|
|
AU2014292086B2
(en)
|
2013-07-19 |
2019-08-08 |
Boehringer Ingelheim Vetmedica Gmbh |
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
MX375936B
(es)
|
2013-12-04 |
2025-03-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Composiciones farmaceuticas mejoradas de pimobendan.
|
|
US10537570B2
(en)
|
2016-04-06 |
2020-01-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
|